학술논문

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
Document Type
Journal Article
Source
Journal of Clinical Oncology; 11/20/2008, Vol. 26 Issue 33, p5326-5334, 9p
Subject
Language
ISSN
0732183X